Patents by Inventor Matthew VanPelt

Matthew VanPelt has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • LARGE SCALE CAR-T IMMUNE CELL MANUFACTURING METHOD UTILIZING LENTIVIRAL VECTOR TRANSFECTION
    Publication number: 20240132841
    Abstract: The present disclosure provides novel and efficient methods and lentiviral vectors for manufacturing a population of immune cells engineered to express a Chimeric Antigen Receptor (CAR), an engineered T cell receptor (TCR), and/or a nucleic acid sequence encoding a polypeptide that enhances the immune cell function, or a functional derivative thereof in less than 72 hours; engineered cells generated by the methods, compositions comprising said cells and methods of treating a disease or condition using said cells.
    Type: Application
    Filed: October 5, 2023
    Publication date: April 25, 2024
    Applicant: Kite Pharma, Inc.
    Inventors: Felipe Bedoya, David Barrett, Vijay Gopal Reddy Peddareddigari, Namrata Choudhari, Matthew VanPelt